Please use this identifier to cite or link to this item: doi:10.22028/D291-43407
Volltext verfügbar? / Dokumentlieferung
Title: 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer
Author(s): Gargano, Emanuele M.
Mohamed, Abdelrahman
Abdelsamie, Ahmed S.
Mangiatordi, Giuseppe F.
Drzewiecka, Hanna
Jagodziński, Paweł P.
Mazzini, Arcangela
van Koppen, Chris J.
Laschke, Matthias W.
Nicolotti, Orazio
Carotti, Angelo
Marchais-Oberwinkler, Sandrine
Hartmann, Rolf W.
Frotscher, Martin
Language: English
Title: ACS Medicinal Chemistry Letters
Volume: 12
Issue: 12
Pages: 1920-1924
Publisher/Platform: ACS
Year of Publication: 2021
Free key words: 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1)
nonsmall cell lung cancer (NSCLC)
steroidogenic enzyme inhibition
drug design
structure−activity relationship (SAR)
molecular docking
DDC notations: 610 Medicine and health
500 Science
Publikation type: Journal Article
DOI of the first publication: 10.1021/acsmedchemlett.1c00462
URL of the first publication: https://pubs.acs.org/doi/10.1021/acsmedchemlett.1c00462
Link to this record: urn:nbn:de:bsz:291--ds-434076
hdl:20.500.11880/38920
http://dx.doi.org/10.22028/D291-43407
ISSN: 1948-5875
Date of registration: 8-Nov-2024
Description of the related object: Supporting Information
Related object: https://ndownloader.figstatic.com/files/31520696
Faculty: M - Medizinische Fakultät
NT - Naturwissenschaftlich- Technische Fakultät
Department: M - Chirurgie
NT - Pharmazie
Professorship: M - Prof. Dr. Michael D. Menger
NT - Prof. Dr. Rolf W. Hartmann
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
There are no files associated with this item.


Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.